Implications of COVID-19 for patients with pre-existing digestive diseases: an update

Affiliations

¹ Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
² Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
³ Department of Gastroenterology, Sheba Medical Center, Tel-HaShomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁴ Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
⁵ Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
⁶ National Institute for Health Research, Biomedical Research Institute, Institute of Translational Medicine, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁷ Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China. Electronic address: chenminhu@mail.sysu.edu.cn.

Comment

Ren Mao et al. Lancet Gastroenterol Hepatol. 2021 Apr.

. 2021 Apr;6(4):258-260.

doi: 10.1016/S2468-1253(21)00025-X. Epub 2021 Feb 2.

¹ Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
² Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
³ Department of Gastroenterology, Sheba Medical Center, Tel-HaShomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁴ Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
⁵ Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
⁶ National Institute for Health Research, Biomedical Research Institute, Institute of Translational Medicine, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁷ Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China. Electronic address: chenminhu@mail.sysu.edu.cn.

No abstract available

Comment on

Implications of COVID-19 for patients with pre-existing digestive diseases.
Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, Wu KC, Chen MH; Chinese Society of IBD, Chinese Elite IBD Union; Chinese IBD Quality Care Evaluation Center Committee. Mao R, et al. Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. doi: 10.1016/S2468-1253(20)30076-5. Epub 2020 Mar 11. Lancet Gastroenterol Hepatol. 2020. PMID: 32171057 Free PMC article. No abstract available.

1. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–1833. - PMC - PubMed
1. Wong GL, Wong VW, Thompson A, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020;5:776–787. - PMC - PubMed
1. Mao R, Liang J, Shen J, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5:425–427. - PMC - PubMed
1. Ioannou GN, Liang PS, Locke E, et al. Cirrhosis and SARS-CoV-2 infection in US veterans: risk of infection, hospitalization, ventilation and mortality. Hepatology. 2020 doi: 10.1002/hep.31649. published online Nov 21. - DOI - PMC - PubMed
1. Marjot T, Moon AM, Cook JA, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2020 doi: 10.1016/j.jhep.2020.09.024. published online Oct 6. - DOI - PMC - PubMed